Mattia Colli

Dr. Mattia Colli

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2023 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
Alessandro GennaiAlessandro Gennai
Alessandro Gennai
MBMonica Baldessin
Monica Baldessin
Fabrizio MelfaFabrizio Melfa
Fabrizio Melfa
BBBruno Bovani
Bruno Bovani
ACAlessandra Camporese
Alessandra Camporese
PTPiero Tesauro
Piero Tesauro
Background: The aging process starts in the center of the face, in the periocular region and around the mouth, with a combination of volume loss, tissue descent, deepened wrinkles, and the loss of skin structure and quality. Recently, several studies have demonstrated the efficacy of therapies based on autologous adipose tissue grafting, which leverages the properties of stromal vascular fraction (SVF) and adipose-derived mesenchymal stem cells (ADSCs) to accelerate the regenerative processes of the skin. This study aims to verify the ability of guided superficial enhanced fluid fat injection (SEFFI) in the facial area to correct volume loss and skin aging, proving that this standardized procedure has a very low rate of complications. Methods: We retrospectively collected data from 2365 procedures performed in Italian centers between 2019 and 2021. Guided SEFFI was performed alone or combined with cosmetic treatments, including the use of hyaluronic acid filler, suspension threads, synthetic calcium hydroxylapatite, botulin toxin, and microneedling. Results: guided SEFFI was used alone in more than 60% of the patients and in all facial areas. In about one-tenth of the patients, guided SEFFI was combined with a botulin toxin treatment or hyaluronic acid filling. Other procedures were used more rarely. Ecchymosis in the donor or injection sites was the most frequent adverse event but was only observed in 14.2% and 38.6% of the patients, respectively. Conclusions: The guided SEFFI technique is standardized and minimally invasive, leading to very few complications. It constitutes a promising antiaging medical treatment that combines effectiveness, safety, and simplicity.

Verified
Journal Article
Open access
PDF file
MBMichela Bosetti
Michela Bosetti
PBPaolo Boffano
Paolo Boffano
AMAlice Marchetti
Alice Marchetti
Massimiliano LeighebMassimiliano Leigheb
Massimiliano Leigheb
Mattia ColliMattia Colli
Mattia Colli
MBMatteo Brucoli
Matteo Brucoli
The objectives of this study were to compare platelet-rich plasma (PRP) from patients with different concentrations of platelets and to assess the influence of these PRP preparations on human osteoblast (hOB) activity. In the literature, growth factors released by activated platelets have been considered responsible for the active role of PRP on bone regeneration but no specific role has been attributed to lysophosphatidic acid (LPA) as a possible effector of biological responses. In this study, patients were grouped into either group A (poor in platelets) or group B (rich in platelets). Clots from PRP fraction 2 (F2-clots), obtained with CaCl2 activation of PRP from the two groups, were compared macroscopically and microscopically and for their mechanical properties before testing their activity on the proliferation and migration of hOB. LPA was quantified before and after PRP fractioning and activation. The fibrin network of F2-clots from patients with a lower platelet concentration had an organized structure with large and distinct fibers while F2-clots from patients in group B revealed a similar structure to those in group A but with a slight increase in density. ELISA results showed a significantly higher plasma level of LPA in patients with a higher platelet concentration (group B) in comparison to those in group A (p < 0.05). This different concentration was evidenced in PRP but not in the clots. Depending on the number of platelets in patient’s blood, a PRP-clot with higher or lower mechanical properties can be obtained. The higher level of LPA in PRP from patients richer in platelets should be considered as responsible for the higher hOB activity in bone regeneration.

Verified
Journal Article
Open access
PDF file
GHGhina Al Haj
Ghina Al Haj
Federica ReyFederica Rey
Federica Rey
TGToniella Giallongo
Toniella Giallongo
Mattia ColliMattia Colli
Mattia Colli
BMBarbara Marzani
Barbara Marzani
Stephana CarelliStephana Carelli
Stephana Carelli
Understanding the molecular basis of adipogenesis is vital to identify new therapeutic targets to improve anti-obesity drugs. The adipogenic process could be a new target in the management of this disease. Our aim was to evaluate the effect of GMG-43AC, a selective peroxisome proliferator-activated receptor γ (PPARγ) modulator, during adipose differentiation of murine pre-adipocytes and human Adipose Derived Stem Cells (hADSCs). We differentiated 3T3-L1 cells and primary hADSCs in the presence of various doses of GMG-43AC and evaluated the differentiation efficiency measuring lipid accumulation, the expression of specific differentiation markers and the quantification of accumulated triglycerides. The treatment with GMG-43AC is not toxic as shown by cell viability assessments after the treatments. Our findings demonstrate the inhibition of lipid accumulation and the significant decrease in the expression of adipocyte-specific genes, such as PPARγ, FABP-4, and leptin. This effect was long lasting, as the removal of GMG-43AC from culture medium did not allow the restoration of adipogenic process. The above actions were confirmed in hADSCs exposed to adipogenic stimuli. Together, these results indicate that GMG-43AC efficiently inhibits adipocytes differentiation in murine and human cells, suggesting its possible function in the reversal of adipogenesis and modulation of lipolysis.

17 January 2024 in Cells
Verified
Journal Article
Open access
PDF file
MBMaxime BONNET
Maxime BONNET
CECéline Ertlen
Céline Ertlen
MSMostafa SEBLANI
Mostafa SEBLANI
JBJean-Michel Brézun
Jean-Michel Brézun
TCThelma Coyle
Thelma Coyle
TMTanguy MARQUESTE
Tanguy MARQUESTE
Traumatic spinal cord injuries (SCIs) often result in sensory, motor, and vegetative function loss below the injury site. Although preclinical results have been promising, significant solutions for SCI patients have not been achieved through translating repair strategies to clinical trials. In this study, we investigated the effective potential of mechanically activated lipoaspirated adipose tissue when transplanted into the epicenter of a thoracic spinal contusion. Male Sprague Dawley rats were divided into three experimental groups: SHAM (uninjured and untreated), NaCl (spinal cord contusion with NaCl application), and AF (spinal cord contusion with transplanted activated human fat). Pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) were measured to assess endogenous inflammation levels 14 days after injury. Sensorimotor recovery was monitored weekly for 12 weeks, and gait and electrophysiological analyses were performed at the end of this observational period. The results indicated that AF reduced endogenous inflammation post-SCI and there was a significant improvement in sensorimotor recovery. Moreover, activated adipose tissue also reinstated the segmental sensorimotor loop and the communication between supra- and sub-lesional spinal cord regions. This investigation highlights the efficacy of activated adipose tissue grafting in acute SCI, suggesting it is a promising therapeutic approach for spinal cord repair after traumatic contusion in humans.

Verified
Journal Article
Open access
PDF file
Mattia ColliMattia Colli
Mattia Colli
Salvatore GiordanoSalvatore Giordano
Salvatore Giordano
EDEnrico Dondè
Enrico Dondè
Alessandro GennaiAlessandro Gennai
Alessandro Gennai
Background: Gluteal augmentation and reshaping have recently gained popularity due to growing patient demand. The rising number of intramuscular gluteal augmentation procedures has led to a corresponding increase in implants, although this has not reduced noticeable esthetic flaws and relatively common postoperative complications. The patient often opts for a secondary gluteal replacement implant. However, studies on this procedure are scarce. Methods: We describe our secondary submuscular gluteal implant replacement technique in patients complaining about dislocation or complications with the primary intramuscular gluteal implant. This procedure involved creating a new round implant pocket in a deeper anatomical plane while keeping the gluteus maximus muscle bridge that joins the intramuscular pocket with the submuscular pocket as intact as possible. To achieve this result, we describe the safest way to remove the intramuscular implant: a small incision is performed posterior to the iliac crest, through which the intramuscular gluteal implant is removed via a small intramuscular-subcutaneous tunnel. We reviewed surgical data, focusing on implant size choice and postoperative complications. Results: We performed this technique on 108 patients. The most frequent complications included three cases of laceration of the muscular bridge between the old intramuscular plane and the new submuscular pocket, resulting in both pockets merging, and eight cases with temporary nerve pain lasting a few days postoperatively. Conclusions: This study validates our approach for addressing and preventing dislocation or other complications from intramuscular gluteal augmentation procedures with implants by applying a safe technique that involves replacing the intramuscular implant with a submuscular one.

23 April 2023 in Preprints.org
Verified
Preprint
Open access
PDF file
Alessandro GennaiAlessandro Gennai
Alessandro Gennai
MBMonica Baldessin
Monica Baldessin
Fabrizio MelfaFabrizio Melfa
Fabrizio Melfa
BBBruno Bovani
Bruno Bovani
ACAlessandra Camporese
Alessandra Camporese
PTPiero Tesauro
Piero Tesauro
Background: The ageing process starts in the center of the face, in the periocular region and around the mouth, with a combination of volume loss and tissue descent, wrinkles deepen, and loss of skin structure and quality. Recently, several studies proved the efficacy of therapies based on the autologous adipose tissue grafting that leverages the properties of stromal vascular fraction (SVF) and adipose derived mesenchymal stem cells (ADSCs) to accelerate the regenerative processes of the skin. This study aimed to verify the ability of the guided Superficial Enhanced Fluid Fat Injection (SEFFI) in the facial area to correct volume loss and skin aging and proved the very low rate of complications of this standardized procedure . Methods: we retrospectively collected data from 2,365 procedures performed in Italian centers between 2019 and 2021. Guided SEFFI was performed alone or combined with cosmetic treatments, including the use of hyaluronic acid filler, suspension threads, synthetic calcium hydroxylapatite, botulin toxin, and microneedling. Results: SEFFI was used alone in more than 60% of the patients, and in all face areas. In about one tenth of patients SEFFI was combined with botulin toxin treatment or hyaluronic acid filling. Other procedures were used more rarely. Ecchymosis in the donor or injection sites was the most frequent event, and yet observed in only 14.2% and 38.6% of patients, respectively. Conclusions: The SEFFI technique is standardized and minimally invasive, leading to very few complications. It can be a promising antiaging medical treatment that combines effectiveness, safety, and simplicity.